Report on Webinar Series Cell and Gene Therapy: From Concept to Clinical Use

With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Focus Group in late 2020, a webinar series reviewing the current and emerging trends in cell and gene therapy was held virtually in May 2021. This webinar series was timely given the recent withdrawal of...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher F. van der Walle (Author), Christine Dufès (Author), Arpan S. Desai (Author), Julie Kerby (Author), Joanne Broadhead (Author), Alice Tam (Author), Zahra Rattray (Author)
Format: Book
Published: MDPI AG, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9bd39ba2c93c48cab4aae13fdbdd5c9c
042 |a dc 
100 1 0 |a Christopher F. van der Walle  |e author 
700 1 0 |a Christine Dufès  |e author 
700 1 0 |a Arpan S. Desai  |e author 
700 1 0 |a Julie Kerby  |e author 
700 1 0 |a Joanne Broadhead  |e author 
700 1 0 |a Alice Tam  |e author 
700 1 0 |a Zahra Rattray  |e author 
245 0 0 |a Report on Webinar Series Cell and Gene Therapy: From Concept to Clinical Use 
260 |b MDPI AG,   |c 2022-01-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14010168 
500 |a 1999-4923 
520 |a With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Focus Group in late 2020, a webinar series reviewing the current and emerging trends in cell and gene therapy was held virtually in May 2021. This webinar series was timely given the recent withdrawal of the United Kingdom from the European Union and the global COVID-19 pandemic impacting all sectors of the pharmaceutical sciences research landscape globally and in the UK. Delegates from the academic, industry, regulatory and NHS sectors attended the session where challenges and opportunities in the development and clinical implementation of cell and gene therapies were discussed. Globally, the cell and gene therapy market has reached a value of 4.3 billion dollars in 2020, having increased at a compound annual growth rate of 25.5% since 2015. This webinar series captured all the major developments in this rapidly evolving area and highlighted emerging concepts warranting cross-sector efforts from across the community in the future. 
546 |a EN 
690 |a cell therapy 
690 |a gene therapy 
690 |a similars 
690 |a manufacture 
690 |a in vivo gene therapy 
690 |a viral vectors 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 1, p 168 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/1/168 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/9bd39ba2c93c48cab4aae13fdbdd5c9c  |z Connect to this object online.